Registry study for chronic lymphocytic leukemia patients
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study is a registry that collects information about people with certain types of leukemia. It may help researchers understand the disease course and how patients are treated, including people who are newly diagnosed, currently treated, referred for transplant, or have relapsed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of a specific leukemia type (CLL or related conditions).
- You are 18 years old or older.
- You can read and sign a written consent form for the study.
- You are in one of these situations: newly diagnosed (not needing treatment yet), receiving standard treatment, considering a transplant (HSCT) evaluation, or having relapsed disease.
- Your diagnosis is clearly confirmed by the treating team.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This registry tracks people with non-Hodgkin lymphoma who are starting a new line of systemic therapy. It collects information to better understand how treatments work in real life, and optionally asks you to fill out surveys about your symptoms and quality of life.
This study collects information from people diagnosed with chronic lymphatic leukemia. It may help doctors better understand the disease, track patient needs, and improve future care.
This is a study that looks back and forward at people diagnosed with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or a related early condition called MBL. It aims to improve how these conditions are recognized and managed over time in Italy.
This study follows people newly diagnosed with chronic lymphocytic leukemia (CLL), a type of blood cancer, to learn more about the disease and how it progresses. By participating, you help researchers understand CLL better, which may improve future treatments.
This study is a disease registry that collects medical information from children who have hemophagocytic lymphohistiocytosis (HLH) or are suspected to have it. It helps doctors better understand HLH and how it affects patients over time.
This study is a cancer registry that collects information from people with lymphoma, Hodgkin disease, or myeloma. It helps researchers understand these cancers better by using real-world patient data.
Hear when a new SLL trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.